Micafungin In Sodium Chloride Injection
Product Images NDC 0338-9053
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Micafungin In Sodium Chloride (NDC 0338-9053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Representative Container Label Ndc 0338-9051-01 Panel 1 Of 2 (Image 02)
This is a description of a medication called Micafungin. It is available in a 50 mg / 50 mL (1 mg / mL) solution for intravenous infusion. The solution is packaged in a single-dose GALAXY container. It is important to discard any unused portion of the medication.
This medication should only be used for intravenous infusion and should not be mixed with any other medications or additives. It should not be used in series connections and it is important to check for minute leaks and solution clarity.
Each 50 mL bag contains 50 mg of Micafungin (equivalent to 50.87 mg of Micafungin Sodium), as well as other ingredients such as Citric Acid, Sodium Chloride, Sodium Citrate, and Water for Injection. The dosage should be determined according to the prescribing information.
The medication should be stored refrigerated at 2°C to 8°C (36°F to 46°F), in the original carton to protect from light. It should not be frozen. If needed, it can be stored at room temperature up to 25°C (77°F) for up to 30 days in the original carton. After 30 days at room temperature, the medication should be discarded.
The product is manufactured by Baxter and is a registered trademark of Baxter International Inc. The Baxter Healthcare Corporation is located in Dearfield, USA.*
Representative Container Label Ndc 0338-9051-01 Panel 2 Of 2 (Image 03)
Representative Container Label Ndc 0338-9053-01 Panel 1 Of 2 (Image 04)
Representative Container Label Ndc 0338-9053-01 Panel 2 Of 2 (Image 05)
Representative Container Label Ndc 0338-9055-01 Panel 1 Of 2 (Image 06)
This is a description of a medication called Micafungin, which is delivered through intravenous infusion. The medication is supplied in a 150 mL single-dose bag containing 150 mg of Micafungin. The bag also contains other ingredients such as Citric Acid, Sodium Chloride, Sodium Citrate, Dihydrate, and Water for Injection. The bag must be discarded if the medication is not fully used. It is important not to add any additional medications or additives to the bag and not to use it in series connections. The bag should be checked for any leaks and the solution should be clear before use. The storage instructions indicate that the bag should be refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect it from light. It should not be frozen. If necessary, the bag can be stored at room temperature up to 25°C (77°F) for up to 30 days in the original carton. After 30 days at room temperature, the bag should be discarded. The manufacturer of the medication is Baxter Healthcare Corporation, located in Deerfield, IL, USA.*
Representative Container Label Ndc 0338-9055-01 Panel 2 Of 2 (Image 07)
Representative Carton Label Ndc 0338-9051-01 Panel (Image 08)
Representative Carton Label Ndc 0338-9053-01 Panel (Image 09)
Representative Carton Label Ndc 0338-9055-01 Panel (Image 10)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.